Banaval,Editor, IJMPO, Associate Professor,Division of Pediatric Oncology, Department of Medical Oncology, 1 Professor and Head, Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai – 400 012, India

India, in numerous ways, is sparkling today. It has changed in to a monetary force to be reckoned with and is scheduled to turn into the third biggest economy on the planet. It has taken monster steps toward mitigating destitution and disposing of station and orientation imbalance. Unfortunately, this financial advancement has not permeated down to different spaces, including clinical consideration. Forus,worried about the consideration of youngsters with disease, the condition of pediatric oncology in the nation today leaves a parcel to be wanted.Progress in Pediatric Oncology is one of the greatest achievement stories in oncology somewhat recently.

Pediatric oncology as a specialty was basically nonexistent in the mid 1980s in India. Most youngsters were dealt with, frequently fruitlessly, by grown-up oncologists in a couple of disease focuses or on the other hand by self-prepared pediatricians in clinical universities. There was absence of good quality pediatric disease units (PCU) and multidisciplinary or convention based care. There were just a small bunch of pediatric oncologists, who were normally prepared abroad. The primary devoted pediatric malignant growth unit was begun in Goodbye Commemoration Emergency clinic in 1985.[3] In a cross country study of pediatric oncology administrations in 1988, half of malignant growth focuses had grown-up oncologists treating youngsters, just 10% had prepared pediatric oncologists, and under 15% had devoted beds for pediatric patients or offices for platelet transfusion.[4] A comparable study done as of late in more than 275 clinical schools or malignant growth communities uncovered a superior yet a long way from ideal picture - over half of clinical schools didn't have offices or ability for treating kids with cancer.[5] Even in the treating focuses, accessibility of offices like immunophenotyping, atomic imaging, cytogenetics, prepared oncology attendants, nutritionists, radiotherapy, blood parts and morphine is exceptionally restricted.

Aside from unfortunate framework and absence of prepared staff, sociocultural also, monetary factors like restricted monetary assets obliviousness and malignant growth ignorance add to cutting edge show and unfortunate result of life as a youngster malignant growths in India.[6] Regardless of these issues, the result of pediatric diseases has steadily worked on in the country over the most recent forty years. The result of hematological malignant growths as far as long haul endurance has extraordinarily improved from 20% to 60% in intense lymphoblastic leukemia (ALL), from 70% to over 90% in Hodgkin's sickness, from 30% to 70% in non-Hodgkin's lymphoma (NHL) and from 10% to 40% in intense myeloblastic leukemia (AML).[7-13] Likewise, the result in strong cancers has likewise moved along. Be that as it may, the result is still significantly poor contrasted with western figures, particularly in growths like retinoblastoma, leukemias, CNS growths and microorganism cell cancers. Besides, there is extensive uniqueness in results between focuses with a couple accomplishing result similar toward the west.[6,11-13]

The groundwork of pediatric oncology research is exact information on the study of disease transmission of experience growing up malignant growths in the country. Sadly, there is a genuine lack of epidemiologic information on pediatric tumors in India. There was practically no information on frequency or dissemination of pediatric malignant growths until 1982, when the Public Disease Vault Program (NCRP) was begun. From six libraries and inclusion of under 2% of the populace, the NCRP has extended to 18 vaults and over 5% coverage.[14] Nonetheless, the information on pediatric tumors are as yet restricted and show extraordinary variety between various populaces in India. The age-normalized paces of young life malignant growths are most noteworthy (108 for each million) in metropolitan regions, trailed by other metropolitan (86 for every million) and provincial (53 for every million) regions in India. Aside from genuine contrasts in rate, these numbers likewise possible reflect different variables like underdiagnosis and underascertainment in semiurban or provincial regions with restricted accessibility of symptomatic and clinical facilities.[15] To supplement these endeavors, a non-legislative association called "JivDaya Establishment" has as of late sent off the Indian Pediatric Oncology Initiative™, with free admittance to an online webbased India Pediatric Oncology Data set (IndiaPOD) and preparing for information chiefs at different PCUs. This would assist with making numerous new PCU-libraries, which will diminish the underascertainment of cases. Besides, imminent information assortment in regards to examples of care and result at each PCU would give individual establishments the capacity to steadily further develop care and act as a stage for cooperative examinations in the future.[16] Our nation comes up short on culture of coordinated clinical examination exemplified by virtual shortfall of good imminent distributed examinations on the study of disease transmission, science or result of young life malignant growths.

The advantages of arsenic in pediatric APML and high-portion cytarabine in T-intense lymphoblastic leukemia (T-ALL) are instances of significant clinical perceptions by Indian centers.[17,18] Around the world, the result of pediatric tumors has moved along through reception of uniform rules and efficient enrolment of patients on imminent multicentric clinical preliminaries directed by public agreeablem groups.[19] Nonetheless, India misses the mark on public pediatric oncology research bunch and under 15% patients are enlisted on clinical preliminaries contrasted with more than 90% in the west.[5,20] A significant exertion at multicenter cooperation was the one between the US Public Malignant growth Establishment and three Indian habitats, which prompted the improvement of the MCP-841 convention for pediatric ALL. This convention has been one of the main achievement accounts of the Indian pediatric oncology local area with long haul endurance in pediatric ALL improving from 20 to 60% with the inescapable reception of MCP-841. This was conceivable using a uniform treatment routine, steady improvement in the convention with neighborhood input, efficient information assortment and admittance to experts.[6,8] We accept that there are significant illustrations gained from the MCP-841 experience that would serve us well as we push ahead.

The pediatric oncology schooling has three critical objective gatherings and objective

1. Give formal pediatric hematology-oncology preparing partnerships to postgraduate understudies all together to make a pool of scholastically situated pediatric oncologists.

2. Give functional momentary preparation to intrigued pediatricians for shared care in satellite habitats.

3. To instruct essential consideration professionals and pediatricians in the early conclusion and brief reference of life as a youngster malignant growths. There was no conventional cooperation program in pediatric hematology-oncology until 2008. As of late, a couple foundations have begun offering partnerships or degrees under the aegis of public board or other rumored colleges. The initiation of projects such as DM in Pediatric Hematology-Oncology in presumed establishments like the Post Graduate Foundation of Clinical Instruction and Exploration is an amazing starting that other enormous focuses need to imitate. For shared care, an significant drive is the Public Preparation Program in The Pediatric Hematology Oncology (PHO) Chapter of the American Cancer Society launched Practical Pediatric Oncology (NTP-PPO).The Indian Academy of Pediatrics (IAP) will deliver useful giving interested clinicians training. [21] For early sensitization rapid referral and accurate diagnosis, the Indian Cooperative.

The PromOTEPediatric campaign (Promotion of Oncology Training) has recently been proposed by the Oncology Network. & Instruction in Childhood Cancers). These actions in advancing the cause of education in paediatric oncology are in their infancy and would benefit from robust and maintaining support from all interested parties to a significant and long-lasting effect.

What should be the future course of pediatric oncology in India?

The future methodology ought to zero in on every one of the three parts of pediatric oncology. To fortify pediatric oncology administration, the most ideal way forward is through ideal use of existing foundation by creation or expansion of PCUs at college clinics and provincial malignant growth centers,equipped with fundamental symptomatic and remedial offices. These PCUs ought to be connected to satellite focuses with pediatricians prepared in shared care. To advance pediatric oncology research, a significant starting step would be the formation of a public youth malignant growth vault that could create information connected with the study of disease transmission and outcome like the Reconnaissance The study of disease transmission and Final products (Soothsayer) program in US. This library could order the imminent information accumulated through cross country use of IndiaPOD alongside NCRP. The main step would be the foundation of a public pediatric oncology research bunch.

Pediatrics for greatest effect.All in all, pediatric oncology in India needs a purposeful, cooperative and complex work to arrive at worldwide norms. This is additionally significant in request to meet its commitment to guarantee the crucial right of every kid to get great quality medical care and chance of fix as expressed underneath by Ponte di Legno bunch on the right of youngsters with leukemia: "All supporters of this reminder, addressing most of the Adolescence Leukemia Treatment Consortia, herewith stress the right of all kids on the planet to full admittance to the fundamental therapy of ALL and different malignant growths, and call upon all specialists worried to perceive and uphold all measures that advance this."[22] Finally, we all including doctors, analysts, disease transmission specialists, directors, support gatherings, and all people devoted to the powerful therapy of experience growing up disease in India ought to endeavor to satisfy the fantasy of legendry Danny Thomas, the organizer behind St. Jude Kids' Exploration Clinic that.

1. Gurney JG, Bondy ML. Epidemiology of childhood cancer.In: Pizzo PA, Poplack DG, editors. Priciples and Practice of Pediatric Oncology. 5th ed. Philadelphia; Lippincott Williams and Wilkins: 2006. p. 2-14.

2. Barr R, Riberio R, Agarwal B, Masera G, Hesseling P, Magrath I. Pediatric Oncology in Countries with Limited Resources. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 1605-17.

3. Advani SH, Agarwal R, Venugopal P, Saikia TK. Pediatric oncology in India. Indian J Pediatr 1987;54:843-5.

4. Shenoy S, Christo GG, Venkatesh A. Pediatric cancer care in India: A national survey. Indian J Cancer 1990;27:91-6.

5. Arora R, Arora B. Delivering childhood cancer service across India: Current provisions and future options. Pediatr Blood Cancer 2009;53:827

6. Arora B, Kurkure P, Parikh P. Childhood cancers: Perspectives in India. J Indian Med Assoc 2005;103:479-82.

7. Advani SH, Giri NK, Pai SK, Nair CN, Kurkure PA, Tapan SK, et al. Acute lymphoblastic leukemia in childhood: Treatment, results and prognostic factors. Indian J Cancer 1989;26:1808.

8. Magrath I, Shanta V, Advani S, Adde M, Arya LS, Banavali S, et al. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period. Eur J Cancer 2005;41:1570-83.

9. Gopal R, Advani SH, Arora S, Nair CN, Saikia TK, Pai SK, et al. Non-Hodgkin’s lymphoma in children: Clinical, histological and treatment analysis. Indian J Cancer 1987;24:202-9.

10. Arya LS, Dinand V, Thavaraj V, Bakhshi S, Dawar R, Rath GK, et al. Hodgkin’s disease in Indian children: outcome with chemotherapy alone. Pediatr Blood Cancer 2006;46:26-34.

11. Swaminathan R, Rama R, Shanta V. Childhood cancers in Chennai, India, 1990-2001: Incidence and survival. Int J Cancer 2008;122:2607-11.

12. Nandakumar A, Anantha N, Appaji L, Swamy K, Mukherjee G, Venugopal T, et al. Descriptive epidemiology of childhood cancers in Bangalore, India. Cancer Causes Control 1996;7:405-10.

13. Arora RS, Eden TO, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer 2009;46:257-66.

14. Sarin R. Indian National Cancer Control Programme: Setting sight on shifting targets. J Cancer Res Ther 2005;1:240-8.

15. Swaminathan R, Sankaranarayanan R. Under-diagnosis and under-ascertainment of cases may be the reasons for low childhood cancer incidence in rural India. Cancer Epidemiol 2010;34:107-8.

16. Arora B, Kanwar V. Childhood cancers in India: Burden, barriers, and breakthroughs. Indian J Cancer 2009;46:257-9.

17. Banavali S, Arora B, Kurkure PA, Pai S, Gujral S, Laskar S, et al. Improved outcome of children and young adults with T-cell acute lymphoblastic leukemia (T-All) with addition of high dose Ara-C (HDac). 40th SIOP annual meeting abstracts D039; Pg.121.

18. Stiller CA. Centralisation of treatment and survival rates of cancer. Arch Dis Child 1988;63:23-30.

19. Crane K. Overcoming age limits in cancer clinical trials. NCI Cancer Bull 2010;7:8-9.

20. Agarwal BR, Marwaha RK, Kurkure PA. Indian National Training Project Practical Paediatric Oncology (INTPPPO): 2nd National teachers meeting, consensus report. Med Pediatr Oncol 2002;39:251.

21. Pui CH, Schrappe M, Masera G, Nachman J, Gadner H, Eden OB, et al. Ponte di Legno Working Group: Statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop. Leukemia 2004;18:1043-53.

Brijesh Arora, Sripad D . Childhood cancer in India: the past, the present, and the future. World Journal Of Hematology And Oncology 2022.